Description
This product utilizes CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD2 ( clone IOCR20). We employs the HBV (EF1α-BFP-PAX-BamHI) vector components and the SynExpress system of the introns Knock-in/Delayed feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD2
Clone
IOCR20
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
BFP
Promoter
EF1α
Effector Gene
PAX
Insertion Sites
BamHI
Gene Modification
Knock-in
Modification Domain
Introns
Carrier Type
HBV
Transformation Accuracy
0.93
Cell Culture
Aseptic Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.